349
Views
4
CrossRef citations to date
0
Altmetric
Review

Review of the recent clinical trials for PD-1/PD-L1 based lung cancer immunotherapy

, &
Pages 1355-1370 | Received 15 Jun 2021, Accepted 14 Oct 2021, Published online: 08 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhiqiang Yang & Fan He. (2023) An immune cell infiltration landscape classification to predict prognosis and immunotherapy effect in oral squamous cell carcinoma. Computer Methods in Biomechanics and Biomedical Engineering 0:0, pages 1-13.
Read now

Articles from other publishers (3)

Hanyi Fang, Xingyi Wang, Xiaoli Lan & Dawei Jiang. (2023) Positron emission tomography imaging sheds new light on hypoxia and antitumor therapies. Interdisciplinary Medicine 1:2.
Crossref
Yan Zhao, Yuansong Bai, Meili Shen & Yapeng Li. (2022) Therapeutic strategies for gastric cancer targeting immune cells: Future directions. Frontiers in Immunology 13.
Crossref
Xiaojing Zhong, Jiyuan Ying, Haihong Liao, Liying Shen & Yunfei Pan. (2022) Association of thyroid function abnormality and prognosis in non-small-cell lung cancer patients treated with PD-1 inhibitors. Future Oncology 18:18, pages 2289-2300.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.